Liver Stiffness by Transient Elastography Predicts Liver-Related Complications and Mortality in Patients with Chronic Liver Disease
暂无分享,去创建一个
G. Kaplan | C. Coffin | M. Swain | S. Heitman | J. Pang | Scott Zimmer | Sophia Niu | P. Crotty | Jenna Tracey | F. Pradhan | A. Shaheen | R. Myers
[1] M McCarthy,et al. Hepatology , 1999, Rapid Medicine.
[2] A. Dreher. Modeling Survival Data Extending The Cox Model , 2016 .
[3] G. Kaplan,et al. The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations. , 2014, Canadian journal of gastroenterology & hepatology.
[4] V. de Lédinghen,et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography , 2013, Hepatology.
[5] Laura E. Leggett,et al. A health technology assessment of transient elastography in adult liver disease. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[6] A. Cucchetti,et al. Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma , 2012, Annals of surgery.
[7] J. Macías,et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis , 2012, Hepatology.
[8] Y. N. Park,et al. Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis , 2012, PloS one.
[9] S. Mehta,et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease , 2012, Journal of viral hepatitis.
[10] A. Pollett,et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients , 2012, Hepatology.
[11] J. Vinel,et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. , 2011, Journal of hepatology.
[12] J. Talwalkar,et al. Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve? , 2011, Hepatology.
[13] Julien Vergniol,et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. , 2011, Gastroenterology.
[14] Y. N. Park,et al. Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) , 2011, Hepatology.
[15] 최은희,et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). , 2011 .
[16] P. Crotty,et al. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[17] G. Alexander,et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease , 2010, Gut.
[18] T. Heeren,et al. Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection , 2010, The American Journal of Gastroenterology.
[19] V. de Lédinghen,et al. Pitfalls of liver stiffness measurement: A 5‐year prospective study of 13,369 examinations , 2010, Hepatology.
[20] H. Quan,et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population‐based study , 2009, Hepatology.
[21] N. Kato,et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography , 2009, Hepatology.
[22] R. Ehman,et al. Abdominal Magnetic Resonance Elastography , 2009, Topics in magnetic resonance imaging : TMRI.
[23] Hude Quan,et al. Predicting in‐hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods , 2009, Hepatology.
[24] Y. Ngo,et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease , 2009, Hepatology.
[25] H. Quan,et al. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] H. Quan,et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. , 2008, Health services research.
[27] Y. Ngo,et al. An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load , 2008, PloS one.
[28] J M Peron,et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease , 2008, Alimentary pharmacology & therapeutics.
[29] A. fong,et al. Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[30] A. Shaheen,et al. The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[31] Eva Herrmann,et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. , 2008, Gastroenterology.
[32] G. Jung,et al. Model for end-stage liver disease , 2008, Der Chirurg.
[33] A. Shaheen,et al. Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data , 2007, BMC Health Services Research.
[34] Giacomo Belli,et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.
[35] W. Kim,et al. The model for end‐stage liver disease (MELD) , 2007, Hepatology.
[36] Y. Ngo,et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. , 2006, Clinical chemistry.
[37] N. Ganne-Carrié,et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. , 2006, Journal of hepatology.
[38] V. de Lédinghen,et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study , 2005, Gut.
[39] F. Oberti,et al. A novel panel of blood markers to assess the degree of liver fibrosis , 2005, Hepatology.
[40] A. Clouston,et al. Steatosis: Co‐factor in other liver diseases , 2005, Hepatology.
[41] V. de Lédinghen,et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.
[42] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.
[43] G. Kaplan,et al. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[44] D. Thabut,et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C , 2004, Comparative hepatology.
[45] Calyampudi Radhakrishna Rao,et al. Advances in Survival Analysis , 2003, Handbook of Statistics.
[46] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[47] M. Ziol,et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.
[48] Ralph B. D'Agostino,et al. Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures , 2003, Advances in Survival Analysis.
[49] J. Bruzzi,et al. Liver biopsy. , 2001, The New England journal of medicine.
[50] C. Steiner,et al. Comorbidity measures for use with administrative data. , 1998, Medical care.
[51] Brämer Gr. International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.